Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Haptoglobins | 2 | 2018 | 117 | 1.32 | Why? |
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2018 | 1 | 0.76 | Why? |
| Electron-Transferring Flavoproteins | 1 | 2018 | 1 | 0.76 | Why? |
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2018 | 6 | 0.76 | Why? |
| Iron-Sulfur Proteins | 1 | 2018 | 3 | 0.76 | Why? |
| Diabetes Mellitus, Type 2 | 10 | 2020 | 6166 | 0.75 | Why? |
| Metabolic Diseases | 2 | 2020 | 505 | 0.70 | Why? |
| Riboflavin | 1 | 2018 | 84 | 0.69 | Why? |
| Neovascularization, Pathologic | 1 | 2020 | 305 | 0.64 | Why? |
| Human Umbilical Vein Endothelial Cells | 2 | 2019 | 286 | 0.64 | Why? |
| Diabetic Angiopathies | 1 | 2018 | 146 | 0.62 | Why? |
| Aortic Diseases | 1 | 2020 | 362 | 0.61 | Why? |
| Intracranial Thrombosis | 1 | 2020 | 339 | 0.60 | Why? |
| Arterial Occlusive Diseases | 1 | 2020 | 363 | 0.60 | Why? |
| Benzhydryl Compounds | 1 | 2018 | 240 | 0.59 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 436 | 0.57 | Why? |
| Hyperthyroidism | 1 | 2014 | 63 | 0.54 | Why? |
| Glucosides | 1 | 2018 | 359 | 0.54 | Why? |
| Endocrinology | 1 | 2017 | 252 | 0.53 | Why? |
| Dyslipidemias | 1 | 2020 | 791 | 0.52 | Why? |
| Endocrine System Diseases | 1 | 2017 | 282 | 0.51 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.42 | Why? |
| Fasting | 2 | 2018 | 555 | 0.38 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.38 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.37 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.37 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.35 | Why? |
| Hypoglycemic Agents | 2 | 2020 | 2165 | 0.35 | Why? |
| Diabetes Mellitus, Type 1 | 2 | 2021 | 1969 | 0.34 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.33 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.33 | Why? |
| Microfluidics | 2 | 2018 | 171 | 0.32 | Why? |
| Diabetes Mellitus | 4 | 2021 | 8207 | 0.32 | Why? |
| Glycated Hemoglobin A | 2 | 2018 | 1316 | 0.32 | Why? |
| Renin-Angiotensin System | 2 | 2020 | 3661 | 0.29 | Why? |
| Blood Glucose | 3 | 2018 | 3642 | 0.27 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2020 | 3051 | 0.27 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.24 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.22 | Why? |
| Endocrine System | 1 | 2020 | 67 | 0.21 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.19 | Why? |
| Cell Separation | 2 | 2018 | 270 | 0.19 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.19 | Why? |
| Microchip Analytical Procedures | 1 | 2017 | 5 | 0.18 | Why? |
| Sodium-Glucose Transporter 2 | 1 | 2018 | 111 | 0.18 | Why? |
| Basigin | 1 | 2020 | 276 | 0.17 | Why? |
| Vitamin E | 1 | 2018 | 128 | 0.17 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.17 | Why? |
| Heterozygote | 1 | 2018 | 249 | 0.17 | Why? |
| Lab-On-A-Chip Devices | 2 | 2017 | 411 | 0.16 | Why? |
| Pedigree | 1 | 2018 | 502 | 0.16 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.16 | Why? |
| Thyroxine | 1 | 2018 | 250 | 0.16 | Why? |
| Receptors, Cell Surface | 1 | 2020 | 586 | 0.15 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.15 | Why? |
| Energy Metabolism | 1 | 2020 | 451 | 0.15 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.14 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.14 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.14 | Why? |
| Erythrocytes | 1 | 2019 | 617 | 0.13 | Why? |
| Transgender Persons | 1 | 2017 | 322 | 0.13 | Why? |
| Diabetic Ketoacidosis | 1 | 2021 | 622 | 0.12 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.12 | Why? |
| Morbidity | 1 | 2018 | 1426 | 0.12 | Why? |
| Islam | 1 | 2018 | 545 | 0.12 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.11 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.11 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.11 | Why? |
| Singapore | 2 | 2021 | 3641 | 0.11 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
| Coronary Angiography | 1 | 2020 | 2275 | 0.11 | Why? |
| Humans | 23 | 2021 | 930598 | 0.11 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.10 | Why? |
| Chilblains | 1 | 2020 | 1156 | 0.10 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.09 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.09 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Endothelial Cells | 1 | 2019 | 2048 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.09 | Why? |
| Blood Platelets | 1 | 2018 | 1704 | 0.08 | Why? |
| Linear Models | 1 | 2013 | 1914 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Monocytes | 1 | 2018 | 2978 | 0.08 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.08 | Why? |
| Dietary Supplements | 1 | 2018 | 2251 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Male | 9 | 2021 | 367725 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.07 | Why? |
| Biosensing Techniques | 1 | 2018 | 2116 | 0.07 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.07 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.06 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.05 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.05 | Why? |
| Female | 7 | 2021 | 380317 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Adult | 5 | 2020 | 244371 | 0.05 | Why? |
| Aldosterone | 1 | 2020 | 155 | 0.05 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.05 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.05 | Why? |
| Cell Adhesion | 1 | 2019 | 230 | 0.05 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.05 | Why? |
| Middle Aged | 6 | 2020 | 270681 | 0.04 | Why? |
| Chemotaxis, Leukocyte | 1 | 2017 | 82 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2018 | 335 | 0.04 | Why? |
| Biomimetics | 1 | 2017 | 84 | 0.04 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.04 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.04 | Why? |
| Cell Communication | 1 | 2019 | 396 | 0.04 | Why? |
| Phagocytosis | 1 | 2018 | 409 | 0.04 | Why? |
| Tertiary Care Centers | 1 | 2014 | 8248 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Aged | 3 | 2020 | 215776 | 0.04 | Why? |
| Blood Glucose Self-Monitoring | 1 | 2021 | 791 | 0.04 | Why? |
| Proof of Concept Study | 1 | 2017 | 696 | 0.04 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.04 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Hypoglycemia | 1 | 2018 | 406 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Metformin | 1 | 2017 | 640 | 0.03 | Why? |
| Flow Cytometry | 1 | 2018 | 2393 | 0.03 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Prospective Studies | 1 | 2014 | 43301 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.02 | Why? |
| Extracellular Traps | 1 | 2017 | 1036 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Cross-Sectional Studies | 1 | 2013 | 53120 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.02 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.02 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |